Compounding pharmacies in Minnesota

By the PeptideAgent Editorial Team. Draft, pending editorial review. Last verified Sep 22, 2026

The Minnesota Board of Pharmacy regulates compounding pharmacies in Minnesota. Compounded GLP-1 limited. How to check a pharmacy's license, plus verified listings.

Minnesota at a glance

Pharmacy regulator: Minnesota Board of Pharmacy
503A framework: Follows the federal 503A framework
Telehealth prescribing: Regulatory: Telehealth allowed
Asynchronous prescribing: Regulatory: Async unclear
Compounded GLP-1 access: Regulatory: Compounded GLP-1 limited

Verified compounding pharmacies serving Minnesota

No verified compounding pharmacies serving Minnesota are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Who regulates compounding pharmacies in Minnesota

The Minnesota Board of Pharmacy licenses pharmacies under Minn. Stat. chapter 151 (the Pharmacy Practice and Wholesale Distribution Act) and regulates practice through Minnesota Rules chapter 6800. Under section 151.19, a pharmacy located outside Minnesota that dispenses to Minnesota residents and ships prescription drugs into the state must hold a Minnesota nonresident pharmacy license, disclose its home-state licensure, and name the pharmacists dispensing to Minnesota patients; the Board also requires a nonresident pharmacist-in-charge designation. Minnesota has no state bulks list; peptide eligibility follows the federal 503A framework. The Board's published guidance documents and its compounding FAQ page, checked on 2026-09-22, do not address semaglutide salt forms or research-grade ingredients, so this record makes no Minnesota-specific claim about them; the federal 503A limits apply. [1] [3] [4] [6] [7] [8] [9]

Compounded GLP-1 access in Minnesota

Minnesota's statutory examination requirement in section 151.37 does not list GLP-1s, so the main state-specific check for a telehealth GLP-1 program is licensure: a Minnesota-licensed prescriber and a pharmacy holding a Minnesota or nonresident Minnesota license. [2] [4] [12]

Research use only sellers in Minnesota

Minn. Stat. section 151.34 prohibits manufacturing, selling, or delivering adulterated or misbranded drugs and selling legend drugs without a prescription in Minnesota. [5] [13]

Minnesota notes on specific peptides

Semaglutide: Available branded by prescription, including by telehealth; it is not one of the drugs for which Minn. Stat. section 151.37 requires a documented examination. Compounded semaglutide is limited to the federal patient specific exception since the 503A grace period ended April 22, 2025. [2] [12]

How to check a compounding pharmacy in Minnesota

Search the Minnesota Board of Pharmacy license lookup for the pharmacy by name. A pharmacy based elsewhere needs whatever license or registration Minnesota requires before it ships to you. [1] [3] [4] [6] [7] [8] [9]
Ask whether it operates as a 503A pharmacy or a 503B outsourcing facility, and confirm a 503B claim against FDA's outsourcing facility information (see the verification checklist).
Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Minnesota. [5] [13]

Common questions in Minnesota

Can an out-of-state pharmacy ship compounded peptides to me in Minnesota?

Only if it holds a Minnesota nonresident pharmacy license under Minn. Stat. section 151.19. Search the Board of Pharmacy license lookup before ordering. [1] [4]

Can a Minnesota pharmacy compound BPC-157?

No, not from bulk today. BPC-157 is not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk. State boards cannot authorize what federal law does not. Peptides still in FDA Category 2 cannot be compounded either. [9] [10] [11]

All peptide legal questions for Minnesota